Boston Scientific (BSX) Tops Q3 EPS by 4c; beats on guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/2/2026
- S&P 500 ends down; Apple dips ahead of quarterly report
- Apple beats quarterly estimates for profit and revenue
- Marvell agrees $115 billion all-stock deal to buy Lumentum
- Oil drops 7% as Iran signals openness to peace talks
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
Tweet
Share
E-mail
Get Alerts BSX Hot Sheet
Price: $44.32 +5.57%
Financial Fact:
Restructuring charges: 5M
Today's EPS Names:
LTBR, AES, SYRS, More
Financial Fact:
Restructuring charges: 5M
Today's EPS Names:
LTBR, AES, SYRS, More
Join SI Premium – FREE
Boston Scientific (NYSE: BSX) reported Q3 EPS of $0.75, $0.04 better than the analyst estimate of $0.71. Revenue for the quarter came in at $5.07 billion versus the consensus estimate of $4.97 billion.
GUIDANCE:
Boston Scientific sees Q4 2025 EPS of $0.77-$0.79, versus the consensus of $0.76.
Boston Scientific sees FY2025 EPS of $3.02-$3.04, versus the consensus of $2.98.
For earnings history and earnings-related data on Boston Scientific (BSX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Calix, Inc. (CALX) Tops Q3 EPS by 3c; offers guidance
- Black Stone Minerals (BSM) Misses Q3 EPS by 4c
- Cabot Corp. (CBT) Tops Q4 EPS by 7c, Beats on Revenue; Offers FY EPS Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
